Comparative effects of the immediate and the extended release formulations of ciprofloxacin on normal human intestinal microflora

Journal of Chemotherapy

Volumn 23, Issue 3, 2011, Pages 145-149

  Rashid, M ^a   Weintraub, A ^a   Nord, C E ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Ciprofloxacin; Ecology; Intestinal microflora

Indexed keywords

CIPROFLOXACIN;

ADULT; ARTICLE; BACTERIAL COUNT; COMPARATIVE STUDY; CONTROLLED DRUG RELEASE; CONTROLLED STUDY; DRUG DOSAGE FORM COMPARISON; DRUG FECES LEVEL; ENTEROCOCCUS; ESCHERICHIA COLI; EXTENDED DRUG RELEASE; FEMALE; HUMAN; HUMAN EXPERIMENT; IMMEDIATE DRUG RELEASE; INTESTINE FLORA; NORMAL HUMAN; TREATMENT DURATION;

EID: 80052701431     PISSN: 1120009X     EISSN: 19739478     Source Type: Journal    
DOI: 10.1179/joc.2011.23.3.145     Document Type: Article

References (20)

1. Vance-Bryan K, Guay DR, Rotschafer JC. Clinical pharmacokinetics of ciprofloxacin. Clin PharmacoWnet 1990; 19:434-461.
2. Hou SY Cowles VE and Berner B. Gastric retentive dosage forms: a review. Crit. Rev. Ther. Drug Carrier Syst. 2003; 20: 459-497
3. Barnett BJ, Stephens DS. Urinary tract infection: an overview. Am J Med Sci 1997; 314:245-249.
4. Washington CB, Hou SY, Campanella C, Hughes N, Brown S, Bemer B. Pharmacokinetics and pharmacodynamics of a novel extended-release ciprofloxacin in healthy volunteers. J Clin Pharmacol 2005; 45:1236-1244.
5. Fourcroy JL, Berner B, Chiang YK, Cramer M, Rowe L, Shore N. Efficacy and safety of a novel once-daily extended-release ciprofloxacin tablet formulation for treatment of uncomplicated urinary tract infection in women. Antimicrob Agents Chemother 2005; 49:4137-4143.
6. Sullivan A, Edlund C, Nord CE. Effect of antimicrobial agents on the ecological balance of human microflora. Lancet Infect Dis 2001; 1:101-114.
7. Blair KA. Evidence-based management of urinary tract infections across the lifespan: Current update. J Nurse Pract 2007; 3:629-632.
8. Henry DC, Jr., Bettis RB, Riffer E, Haverstock DC, Kowalsky SF, Manning K, et al. Comparison of once-daily extended-release ciprofloxacin and conventional twice-daily ciprofloxacin for the treatment of uncomplicated urinary tract infection in women. Clin Ther 2002; 24:2088-2104.
9. Nord CE, Sillerstrom E, Wahlund E. Effect of tigecycline on normal oropharyngeal and intestinal microflora. Antimicrob Agents Chemother 2006; 50:3375-3380.
10. Murray PBEJ, Jorgensen JH, Landry ML, Pfaller MA. Manual of Clinical Microbiology. 9th ed. Washington, DC: ASM Press; 2007.
11. Delmee M: Laboratory diagnosis of Clostridium difficile disease. Clin Microbiol Infect 2001; 7:411-416.
12. CLSI. Methods for dilution antimicrobial susceptibility test for bacteria that grow aerobically. Approved standard. Seventh edition (M7-A7) Ed: Wayne, PA: Clinically and Laboratory Standards Institute; 2006.
13. CLSI. Methods for antimicrobial susceptibility testing of anaerobic bacteria. Approved standard. Seventh edition (M11-A7) Ed: Wayne, PA: Clinically and Laboratory Standards Institute; 2007.
14. Kahlmeter G, Brown DF, Goldstein FW, MacGowan AP, Mouton JW, Odenholt I, et al. European Committee on Antimicrobial Susceptibility Testing (EUCAST) Technical notes on antimicrobial susceptibility testing. Clin Microbiol Infect 2006; 12:501-503.
15. Brismar B, Edlund C, Malmborg AS, Nord CE. Ciprofloxacin concentrations and impact of the colon microflora in patients undergoing colorectal surgery. Antimicrob Agents Chemother 1990; 34:481-483.
16. Adams DA, Riggs MM, Donskey CJ. Effect of fluoroquinolone treatment on growth of and toxin production by epidemic and nonepidemic Clostridium difficile strains in the cecal contents of mice. Antimicrob Agents Chemother 2007; 51:2674-2678.
17. Appelbaum PC, Hunter PA. The fluoroquinolone antibacterials: past, present and future perspectives. Int J Antimicrob Agents 2000; 16:5-15.
18. Spencer RC. The role of antimicrobial agents in the aetiology of Clostridium difficile-associated disease. J Antimicrob Chemother 1998; 41 Suppl C: 21-27.
19. Alekshun MN, Levy SB. Commensals upon us. Biochem Pharmacol 2006; 71:893-900.
20. Salyers AA, Gupta A, Wang Y. Human intestinal bacteria as reservoirs for antibiotic resistance genes. Trends Microbiol 2004; 12:412-416.